Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke: Results of the MERCI Trial
暂无分享,去创建一个
H. Lutsep | R. Higashida | Wade S. Smith | S. Starkman | J. Saver | C. Kidwell | R. Budzik | M. Marks | G. Sung | Y. Gobin | G. Nesbit | T. Grobelny | M. Rymer | I. Silverman | J. Saver
[1] T. Brott,et al. Approval of the MERCI clot retriever: a critical view. , 2005, Stroke.
[2] M. Fisher,et al. Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke. , 2005, Stroke.
[3] C. Witten,et al. The Food and Drug Administration medical device review process: clearance of a clot retriever for use in ischemic stroke. , 2005, Stroke.
[4] A. Alexandrov,et al. Aggressive Mechanical Clot Disruption: A Safe Adjunct to Thrombolytic Therapy in Acute Stroke? , 2005, Stroke.
[5] Fernando Vinuela,et al. MERCI 1: A Phase 1 Study of Mechanical Embolus Removal in Cerebral Ischemia , 2004, Stroke.
[6] A. Alexandrov,et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. , 2004, The New England journal of medicine.
[7] M. Hartmann,et al. Does acute occlusion of the carotid T invariably have a poor outcome? , 2004, Neurology.
[8] Alexander Norbash,et al. Mechanical Thrombolysis in Acute Ischemic Stroke With Endovascular Photoacoustic Recanalization , 2004, Stroke.
[9] Ims Study Investigators. Combined Intravenous and Intra-Arterial Recanalization for Acute Ischemic Stroke: The Interventional Management of Stroke Study , 2004, Stroke.
[10] A. Ziegler,et al. Age and National Institutes of Health Stroke Scale Score Within 6 Hours After Onset Are Accurate Predictors of Outcome After Cerebral Ischemia: Development and External Validation of Prognostic Models , 2003, Stroke.
[11] Steven Warach,et al. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. , 2003, Journal of vascular and interventional radiology : JVIR.
[12] A. Ringer,et al. Aggressive Mechanical Clot Disruption and Low-dose Intra-arterial Third-generation Thrombolytic Agent for Ischemic Stroke: A Prospective Study , 2002, Neurosurgery.
[13] S. Nakano,et al. Combined direct percutaneous transluminal angioplasty and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion. , 2002, AJNR. American journal of neuroradiology.
[14] W. Hacke,et al. Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic? , 2001, Stroke.
[15] P. Akins,et al. Intra-arterial prourokinase for acute ischemic stroke. , 2000, JAMA.
[16] R. Higashida,et al. Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .
[17] G. Albers,et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. , 1999, JAMA.
[18] J. Sunshine,et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. , 1999, Stroke.
[19] M. Kaste,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.
[20] P Trouillas,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. , 1998, Lancet.
[21] W. Hacke,et al. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. , 1996, Stroke.
[22] W. Hacke,et al. 'Malignant' middle cerebral artery territory infarction : Clinical course and prognostic signs , 1996 .
[23] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[24] W. Hacke,et al. Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. , 1995, AJNR. American journal of neuroradiology.
[25] W. Hacke,et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke , 1992, Annals of neurology.
[26] Gregory,et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. , 1988, Stroke.
[27] E. Braunwald,et al. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. , 1986, Circulation.
[28] W. Hacke,et al. Acute vertebral-basilar thrombosis. Angiologic-clinical comparison and therapeutic implications. , 1986, Acta radiologica. Supplementum.